×
Home Companies Industry Politics Money Opinion LoungeMultimedia Science Education Sports TechnologyConsumerSpecialsMint on Sunday
×

Biocon sees oral insulin partner by March

Biocon sees oral insulin partner by March
Comment E-mail Print Share
First Published: Wed, Nov 23 2011. 03 29 PM IST

Biocon MD Kiran Mazumdar-Shaw
Biocon MD Kiran Mazumdar-Shaw
Updated: Wed, Nov 23 2011. 03 29 PM IST
Bangalore: Biocon Ltd, The country’s largest listed biotechnology company, expects to find a deep-pocketed global partner for its experimental oral insulin pill by end-March, its top executive said on Wednesday.
Biocon MD Kiran Mazumdar-Shaw
“We are in advanced discussions with potential partners,” Biocon’s managing director Kiran Mazumdar-Shaw told the Reuters India Investment Summit in Bangalore.
In January, Biocon had said it was looking for a partner after its oral insulin, IN-105, failed to meet the main goal of an Indian late-stage trial in patients with type-2 diabetes.
Mazumdar-Shaw, however, declined to name any potential partners.
She also said the planned IPO of its contract research organisation, Syngene, was on track.
Comment E-mail Print Share
First Published: Wed, Nov 23 2011. 03 29 PM IST